A Prelaunch QA Checklist for Pharma Programmatic Campaigns
An evidence-and-owner prelaunch QA checklist for pharma programmatic campaigns, with hard stops separated from warnings.
The short answer
Most pharma programmatic errors are cheaper to catch before launch than after. A wrong audience, a missing exclusion, an unapproved creative, or a broken tag can waste budget and create compliance risk within hours. A prelaunch QA checklist catches these. The useful version names an owner for each check, records evidence, and separates hard stops from warnings.
Hard stops vs. warnings
Hard stop: the campaign must not launch until fixed. Examples: unapproved creative, missing required exclusions, wrong target list.
Warning: launch can proceed, but the issue must be fixed soon and tracked. Examples: a secondary tag not yet firing, a minor naming inconsistency.
The checklist
Creative and compliance (hard stops)
- Every creative has a current approval from medical, legal, and regulatory review.
- Creative versions in the platform match the approved versions exactly.
- Required risk information is present and readable in every size and format. See FDA guidance on presenting risk information.
- Click-through URLs go to approved pages.
Audience (hard stops)
- Correct target list or segment, confirmed by name, version, and date.
- Exclusions applied as listed in the exclusion register.
- Age and geography restrictions set.
Inventory and quality
- Allowlists and blocklists applied. (Hard stop)
- Verification and brand safety tags active. (Hard stop)
- Deal IDs correct and active. (Warning if a secondary deal)
Budget and pacing
- Budgets and flight dates match the plan. (Hard stop)
- Frequency caps set. (Hard stop)
- Pacing settings confirmed.
Measurement
- Tags fire correctly. See measurement tag validation. (Hard stop for primary KPI tags)
- Holdout groups set up if part of the design. (Hard stop)
- Naming conventions support reporting.
Record evidence and owner
| Check | Owner | Evidence | Status |
|---|---|---|---|
| Creative approvals | Brand ops | Approval IDs | |
| Target list version | Media lead | File name and date | |
| Exclusions | Activation lead | Platform screenshot | |
| Tags | Ad ops | Test fire log | |
| Holdout | Analytics | Assignment file |
A checkmark without evidence is an assumption.
Check again after launch
Some errors only show after delivery starts. Within 24 to 48 hours, confirm delivery is on the right audience, domains, and creative, and that exclusions are working.
Practical takeaway
Use one checklist for every campaign. Require evidence for each hard stop and a named owner's sign-off before launch.
Sources
- FDA, Presenting Risk Information in Prescription Drug and Medical Device Promotion
- Media Rating Council, Standards and Guidelines
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.